글로벌 파괴적 기분 조절 장애(DMDD) 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 파괴적 기분 조절 장애(DMDD) 시장

파괴적 기분 조절 장애(DMDD) 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 5%의 CAGR로 성장할 것으로 분석합니다.

파괴적 기분 조절 장애(DMDD)는 아이들이 항상 격노하고 사소해 보이는 사건에 대해 화를 내는 정신 건강 상태입니다. DMDD가 있는 아이들은 같은 나이의 다른 아이들과 같은 방식으로 감정을 조절하는 데 어려움을 겪습니다. 이는 심리적 장애입니다. 보통 외동아이에게 진단이 내려집니다. 과민성, 행동적 폭발, 감정 조절 장애가 가장 흔한 증상입니다.

파괴적 기분 조절 장애의 유병률 증가와 의료비 지출 증가는 시장 성장률에 영향을 미치는 주요 요인입니다. 또한 의료 기술의 발전, 정부 자금 지원 증가, 질병과 이용 가능한 치료 옵션에 대한 인식을 확산하기 위한 공공 및 민간 기관의 이니셔티브 증가는 파괴적 기분 조절 장애(DMDD) 시장을 확대할 요인입니다. 마찬가지로, 어린이들 사이에서 스트레스, 우울증 및 불안의 증가는 시장 성장률을 완화할 것입니다.

2021~2028년 예측 기간 동안 연구 개발 활동의 증가와 새로운 시장의 출현은 파괴적 기분 조절 장애(DMDD) 시장에 유익한 기회를 제공할 것입니다.

그러나 약물 치료와 관련된 높은 비용과 부작용은 시장 성장을 방해하는 요인입니다. 인식 부족은 위에서 언급한 예측 기간 동안 파괴적 기분 조절 장애(DMDD) 시장에 더욱 큰 도전이 될 것입니다.

This disruptive mood dysregulation disorder (DMDD) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the disruptive mood dysregulation disorder (DMDD) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Disruptive Mood Dysregulation Disorder (DMDD) Market Scope and Market Size

The disruptive mood dysregulation disorder (DMDD) market is segmented on the basis of treatment, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the disruptive mood dysregulation disorder (DMDD) market is segmented into medication, physiological treatments and others. Medication has been further sub-segmented into antipsychotics, antidepressants, mood stabilizers and stimulants. Physiological treatments have been further sub-segmented into psychotherapy, computer based training and parent training.
• On the basis of symptoms, the disruptive mood dysregulation disorder (DMDD) market is segmented into physical, behavioral, psychosocial and cognitive. Physical symptoms have been further sub-segmented into muscle tension, increased heart rate during temper outbursts and elevated blood pressure. Behavioral symptoms have been further sub-segmented into fits of aggression towards others or property, verbal aggression, behavioral problems in school or at home, angry outbursts and bouts of physical violence. Psychosocial symptoms have been further sub-segmented into extreme irritability and unpredictable anger oscillating moods. Cognitive symptoms have been further sub-segmented into inability to refocus attention and inability to self-regulate emotions.
• On the basis of dosage, the disruptive mood dysregulation disorder (DMDD) market is segmented into tablet, injection and others.
• On the basis of route of administration, the disruptive mood dysregulation disorder (DMDD) market is segmented into oral, intravenous and others.
• On the basis of end-users, the disruptive mood dysregulation disorder (DMDD) market is segmented into clinic, hospital and others.

The disruptive mood dysregulation disorder (DMDD) market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Disruptive Mood Dysregulation Disorder (DMDD) Market Country Level Analysis

Disruptive mood dysregulation disorder (DMDD) market is analyzed and market size information is provided by the country, treatment, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the disruptive mood dysregulation disorder (DMDD) market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the disruptive mood dysregulation disorder (DMDD) market due to the presence of major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Disruptive mood dysregulation disorder (DMDD) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Disruptive Mood Dysregulation Disorder (DMDD) Market Share Analysis

파괴적 기분 조절 장애(DMDD) 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 포함됩니다. 위에 제공된 데이터 포인트는 파괴적 기분 조절 장애(DMDD) 시장 조사와 관련된 회사의 초점에만 관련이 있습니다.

파괴적 기분 조절 장애(DMDD) 시장 보고서에서 다루는 주요 기업으로는 GlaxoSmithKline plc, Pfizer Inc., AstraZeneca, Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Sandoz International GmbH, Apotex Inc., Mylan NV, H. Lundbeck A/S, Allergan, Sanofi, Merck Sharp & Dohme Corp., Teva Pharmaceutical Industries Ltd., Alkermes, Takeda Pharmaceutical Company Limited., OPKO Health, Inc., Intra-Cellular Therapies Inc., Janssen Pharmaceuticals, Inc., Lupin, Novartis AG, Bausch Health Companies Inc., Eli Lilly and Company, Sumitomo Dainippon Pharma Co., Ltd., AbbVie Inc., Dr. Reddy's Laboratories Ltd. 등이 있으며, 그 외 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-67041